Johnson & Johnson Elects JPMorgan President Daniel Pinto to Board

Johnson & Johnson has elected Daniel Pinto, President of JPMorgan Chase, to its Board of Directors effective July 1, 2025. Pinto brings over three decades of financial expertise and leadership from JPMorgan Chase, where he will transition to Vice Chairman after June 2025 until his retirement in 2026. His appointment is expected to enhance Johnson & Johnson's governance, particularly in financial operations, by leveraging his deep understanding of global capital markets to support the company's strategic investments and innovation in healthcare. Pinto will serve on both the Audit Committee and the Compensation & Benefits Committee, contributing valuable insights to the company's financial decision-making processes. Johnson & Johnson's CEO Joaquin Duato emphasized Pinto's exceptional leadership and the significant asset his experience represents in advancing healthcare innovation. Pinto expressed admiration for Johnson & Johnson's commitment to scientific innovation and health outcomes, highlighting his honor to join the board and contribute to improving global health.